-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ranibizumab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ranibizumab Drug Details Ranibizumab (Lucentis, Patizra) is a humanized monoclonal antibody fragment and a...